Skip to main content

Advertisement

Table 1 Characteristics of patient

From: Tuberculosis presenting as immune thrombocytopenic purpura

Day Hb (g/dl) Hct (%) WBC (×109) Plt (×109) Treatment
1 11.2 36 25.1 7.6 Anti-tbc drugs + IVIg
2 8 25 23.1 9.6 Anti-tbc drugs + IVIg+Pred+1 RBC Susp
3 8.1 25 22.7 17.7 Anti-tbc drugs+ Pred+ 2 RBC Susp
4 10.3 33 20.6 15.1 Anti-tbc drugs+ Pred
5 8.6 27 24.5 12.3 Anti-tbc drugs+ Pred+ 1 RBC Susp
6 8.2 24 25.4 4.0 Anti-tbc drugs + Pred + 2 RBC Susp
7 10.1 29 20.6 4.7 Anti-tbc drugs+ Pred
8 10.5 32 17.7 20.2 Anti-tbc drugs+ Pred
9 9.9 31 15.8 36.6 Anti-tbc drugs+ Pred
10 10.3 33 18 59 Anti-tbc drugs+ Pred
11 9.4 28 14 100 Anti-tbc drugs+ Pred
12 9.7 28 18.1 187 Anti-tbc drugs+ Pred
13 9.1 26 15.2 324 Anti-tbc drugs+ Pred
14 9.6 28 17 310 Anti-tbc drugs
45 12.3 37 15.5 304 Anti-tbc drugs
90 14 43 11 300 Anti-tbc drugs
  1. Abbreviations: Anti-tbc drugs: anti-tuberculous drugs, Pred: Prednisolone, Susp: Suspension